Profile
Dr. Robert P.
Lanza, MD PhD, is Chief Scientific Officer at Ocata Therapeutics, Inc.
Dr. Lanza was previously employed as a Director-Transplantation Biology by BioHybrid Technologies, Inc. and an Advisor by Proteus RM LLC.
He received his undergraduate degree from the University of Pennsylvania and a doctorate degree from the University of Pennsylvania.
Former positions of Robert P. Lanza
Companies | Position | End |
---|---|---|
OCATA THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 2016-02-09 |
BioHybrid Technologies, Inc. | Corporate Officer/Principal | 1997-12-31 |
Proteus RM LLC (Venture Capital)
Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Consultant / Advisor | - |
Training of Robert P. Lanza
University of Pennsylvania | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Astellas Institute for Regenerative Medicine
Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
BioHybrid Technologies, Inc. | |
Proteus RM LLC (Venture Capital)
Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Finance |
- Stock Market
- Insiders
- Robert P. Lanza